These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25458642)

  • 41. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics and Vascular Complications of Familial Hypercholesterolemia in Korea.
    Lee SH
    J Atheroscler Thromb; 2016 May; 23(5):532-8. PubMed ID: 26947601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advanced method for the identification of patients with inherited hypercholesterolemia.
    Defesche JC; Lansberg PJ; Umans-Eckenhausen MA; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):59-65. PubMed ID: 15199434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Canadian Cardiovascular Society position statement on familial hypercholesterolemia.
    ; Genest J; Hegele RA; Bergeron J; Brophy J; Carpentier A; Couture P; Davignon J; Dufour R; Frohlich J; Gaudet D; Gupta M; Krisnamoorthy P; Mancini J; McCrindle B; Raggi P; Ruel I; St-Pierre J
    Can J Cardiol; 2014 Dec; 30(12):1471-81. PubMed ID: 25448461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carotid plaque burden as a measure of subclinical coronary artery disease in patients with heterozygous familial hypercholesterolemia.
    ten Kate GL; ten Kate GJ; van den Oord SC; Dedic A; Dharampal AS; Nieman K; de Feyter PJ; Sijbrands EJ; van der Steen AF; Schinkel AF
    Am J Cardiol; 2013 May; 111(9):1305-10. PubMed ID: 23411100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
    Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17).
    Miller PE; Martin SS; Toth PP; Santos RD; Blaha MJ; Nasir K; Virani SS; Post WS; Blumenthal RS; Jones SR
    J Clin Lipidol; 2015; 9(5):676-83. PubMed ID: 26350814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology.
    Bates TR; Burnett JR; van Bockxmeer FM; Hamilton S; Arnolda L; Watts GF
    Heart Lung Circ; 2008 Oct; 17(5):411-3. PubMed ID: 17683986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genetic screening for familial hypercholesterolemia in 1992-1997: primarily younger patients in the care of family physicians].
    ten Asbroek AH; van Lunsen S; Marang-van de Mheen PJ; Gunning-Schepers LJ
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):125-9. PubMed ID: 10674119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
    Brænne I; Kleinecke M; Reiz B; Graf E; Strom T; Wieland T; Fischer M; Kessler T; Hengstenberg C; Meitinger T; Erdmann J; Schunkert H
    Eur J Hum Genet; 2016 Feb; 24(2):191-7. PubMed ID: 26036859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient experiences align with the familial hypercholesterolemia global call to action.
    Jones LK; Walters N; Brangan A; Ahmed CD; Wilemon KA; Campbell-Salome G; Rahm AK; Gidding SS; Sturm AC
    Am J Prev Cardiol; 2022 Jun; 10():100344. PubMed ID: 35517872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document].
    Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F
    Semergen; 2015; 41(1):24-33. PubMed ID: 25042971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Robinson JG
    J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.
    Alonso R; Mata P; Zambón D; Mata N; Fuentes-Jiménez F
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
    Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.